Anker SD - Search Results

1

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.

Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, Brueckmann M, Ofstad AP, Pfarr E, Jamal W, Packer M. Zannad F, et al. Among authors: anker sd. Lancet. 2020 Sep 19;396(10254):819-829. doi: 10.1016/S0140-6736(20)31824-9. Epub 2020 Aug 30. Lancet. 2020. PMID: 32877652

2

Metabolic, functional, and haemodynamic staging for CHF?

Anker SD, Coats AJ. Anker SD, et al. Lancet. 1996 Dec 7;348(9041):1530-1. doi: 10.1016/S0140-6736(05)66163-6. Lancet. 1996. PMID: 8950874 No abstract available.

3

Wasting as independent risk factor for mortality in chronic heart failure.

Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Anker SD, et al. Lancet. 1997 Apr 12;349(9058):1050-3. doi: 10.1016/S0140-6736(96)07015-8. Lancet. 1997. PMID: 9107242

4

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hänlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R. Osterziel KJ, et al. Among authors: anker sd. Lancet. 1998 Apr 25;351(9111):1233-7. doi: 10.1016/S0140-6736(97)11329-0. Lancet. 1998. PMID: 9643742 Clinical Trial.

5

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Niebauer J, et al. Among authors: anker sd. Lancet. 1999 May 29;353(9167):1838-42. doi: 10.1016/S0140-6736(98)09286-1. Lancet. 1999. PMID: 10359409

6

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Anker SD, et al. Lancet. 2003 Mar 29;361(9363):1077-83. doi: 10.1016/S0140-6736(03)12892-9. Lancet. 2003. PMID: 12672310

7

Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.

Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Filippatos GS, et al. Among authors: anker sd. Int J Cardiol. 2003 Jul;90(1):107-13. doi: 10.1016/s0167-5273(02)00535-1. Int J Cardiol. 2003. PMID: 12821225

8

B-type natriuretic peptide serum levels in acute heart failure.

Filippatos GS, Anker SD, Kardaras F. Filippatos GS, et al. Among authors: anker sd. Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6. doi: 10.1016/j.ehj.2004.03.027. Eur Heart J. 2004. PMID: 15191781 No abstract available.

9

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA. Hartmann F, et al. Among authors: anker sd. Circulation. 2004 Sep 28;110(13):1780-6. doi: 10.1161/01.CIR.0000143059.68996.A7. Epub 2004 Sep 20. Circulation. 2004. PMID: 15381643 Clinical Trial.

10

Pathophysiology of peripheral muscle wasting in cardiac cachexia.

Filippatos GS, Anker SD, Kremastinos DT. Filippatos GS, et al. Among authors: anker sd. Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15809526 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,282 results

Search Page